BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9690620)

  • 41. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis.
    Chang CH; Scott GK; Kuo WL; Xiong X; Suzdaltseva Y; Park JW; Sayre P; Erny K; Collins C; Gray JW; Benz CC
    Oncogene; 1997 Apr; 14(13):1617-22. PubMed ID: 9129154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types.
    Chan YJ; Chiou CJ; Huang Q; Hayward GS
    J Virol; 1996 Dec; 70(12):8590-605. PubMed ID: 8970984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural inferences of the ETS1 DNA-binding domain determined by mutational analysis.
    Mavrothalassitis G; Fisher RJ; Smyth F; Watson DK; Papas TS
    Oncogene; 1994 Feb; 9(2):425-35. PubMed ID: 8290254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-affinity DNA-protein interactions of the cellular ETS1 protein: the determination of the ETS binding motif.
    Fisher RJ; Mavrothalassitis G; Kondoh A; Papas TS
    Oncogene; 1991 Dec; 6(12):2249-54. PubMed ID: 1766672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
    Potapova O; Fakhrai H; Baird S; Mercola D
    Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nucleotide sequence of the 5' region of the human platelet-derived growth factor A-chain gene.
    Takimoto Y; Li WY; Wang ZY; Tong BD; Deuel TF
    Hiroshima J Med Sci; 1993 Mar; 42(1):47-52. PubMed ID: 8486521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The oncoprotein v-Ets is less selective in DNA binding than c-Ets-1 due to the C-terminal sequence change.
    Hahn SL; Wasylyk B
    Oncogene; 1994 Sep; 9(9):2499-512. PubMed ID: 8058313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Normal developing rat brain expresses a platelet-derived growth factor B chain (c-sis) mRNA truncated at the 5' end.
    Sasahara M; Amano S; Sato H; Yang JG; Hayase Y; Kaneko M; Sato I; Suzaki M; Hazama F
    Oncogene; 1998 Mar; 16(12):1571-8. PubMed ID: 9569024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptional activation of the immediate early gene pip92 by serum growth factors requires both Ets and CArG-like elements.
    Latinkić BV; Lau LF
    J Biol Chem; 1994 Sep; 269(37):23163-70. PubMed ID: 8083220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene.
    Bories JC; Willerford DM; Grévin D; Davidson L; Camus A; Martin P; Stéhelin D; Alt FW
    Nature; 1995 Oct; 377(6550):635-8. PubMed ID: 7566176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Localization of the 12-O-tetradecanoylphorbol-13-acetate response of the human ornithine decarboxylase promoter to the TATA box.
    Reddig PJ; Kim YJ; Verma AK
    Mol Carcinog; 1996 Oct; 17(2):92-104. PubMed ID: 8890958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 5' untranslated sequences determine degradative pathway for alternate PDGF B/c-sis mRNA's.
    Fen Z; Daniel TO
    Oncogene; 1991 Jun; 6(6):953-9. PubMed ID: 2067847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ets oncogene family.
    Dhulipal PD
    Indian J Exp Biol; 1997 Apr; 35(4):315-22. PubMed ID: 9315229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of proteins binding to the ZII element in the Epstein-Barr virus BZLF1 promoter: transactivation by ATF1.
    Wang YC; Huang JM; Montalvo EA
    Virology; 1997 Jan; 227(2):323-30. PubMed ID: 9018131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Negative regulatory elements in the human ETS1 gene promoter.
    Chen JH; Jeha S; Oka T
    Oncogene; 1993 Jan; 8(1):133-9. PubMed ID: 8423991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel cis-acting elements in the human platelet-derived growth factor B-chain core promoter that mediate gene expression in cultured vascular endothelial cells.
    Khachigian LM; Fries JW; Benz MW; Bonthron DT; Collins T
    J Biol Chem; 1994 Sep; 269(36):22647-56. PubMed ID: 8077216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The tax protein of human T-cell leukemia virus type 1 mediates the transactivation of the c-sis/platelet-derived growth factor-B promoter through interactions with the zinc finger transcription factors Sp1 and NGFI-A/Egr-1.
    Trejo SR; Fahl WE; Ratner L
    J Biol Chem; 1997 Oct; 272(43):27411-21. PubMed ID: 9341193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. c-Ets-1 protein is hyperphosphorylated during mitosis.
    Fleischman LF; Pilaro AM; Murakami K; Kondoh A; Fisher RJ; Papas TS
    Oncogene; 1993 Mar; 8(3):771-80. PubMed ID: 8437861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the human elk-1 promoter. Potential role of a downstream intronic sequence for elk-1 gene expression in monocytes.
    Lehmann U; Brocke P; Dittmer J; Nordheim A
    J Biol Chem; 1999 Jan; 274(3):1736-44. PubMed ID: 9880555
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional identification of regulatory elements within the promoter region of platelet-derived growth factor 2.
    Pech M; Rao CD; Robbins KC; Aaronson SA
    Mol Cell Biol; 1989 Feb; 9(2):396-405. PubMed ID: 2651898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.